A global fund should be created to speed development of much-needed new antibiotics to counter the growing threat of drug-resistant…
Read More
Actavis’ superbug antibiotic gets US approval
The U.S. Food and Drug Administration on Wednesday approved the use of Actavis Plc’s antibiotic, Avycaz, to battle drug-resistant bacteria…
Read More
Unchecked superbugs could kill 10 million a year, cost $100 trillion
Drug-resistant superbugs could kill an extra 10 million people a year and cost up to $100 trillion by 2050 if…
Read More